Generate:Biomedicines

3个月前更新 11 0 0
收藏 0

Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of biology, machine learning, and biological engineering.

所在地：
美国
收录时间：
2024-12-13
打开网站
Generate:BiomedicinesGenerate:Biomedicines
Generate:Biomedicines
Generate:Biomedicines is a pioneering therapeutics company at the intersection of machine learning, biological engineering, and medicine. It specializes in creating breakthrough medicines through generative biology, a novel approach that uses AI to design proteins and other biological molecules with specific therapeutic functions. The company’s Generate Platform integrates machine learning, high-throughput experimentation, and structural determination to enable programmable biology, allowing for the rapid generation of drug candidates across multiple therapeutic modalities.
Key features include:
  • Generative Biology: By studying millions of proteins, Generate:Biomedicines has developed rules to encode specific functions, enabling the creation of novel medicines.
  • Unprecedented Speed and Success Rates: The platform can generate drug candidates with higher efficiency and success rates compared to traditional methods.
  • Diverse Therapeutic Modalities: The platform supports the creation of antibodies, peptides, enzymes, and other protein-based therapies, addressing a wide range of diseases.
  • Addressing Undruggable Targets: Generate:Biomedicines focuses on historically challenging targets, such as GPCRs and ion channels, which are difficult to address with conventional approaches.
  • Clinical Pipeline Advancement: The company has multiple programs in clinical development, including GB-0895 (anti-TSLP) for asthma and GB-7624 (anti-IL-13) for atopic dermatitis.
Generate:Biomedicines is ideal for applications in immunology, inflammation, infectious diseases, and oncology, aiming to democratize biotherapeutics and transform the future of medicine.
打赏微海报分享

数据统计

相关导航

暂无评论

none
暂无评论...